BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12437618)

  • 1. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
    Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
    Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
    J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
    J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
    Lin CC; Chen CL; Concejero A; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Cheng YF; Eng HL
    Am J Transplant; 2007 Jan; 7(1):195-200. PubMed ID: 17227568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
    Cholongitas E; Papatheodoridis GV; Burroughs AK
    J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
    Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
    Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation from hepatitis B core antibody positive donors.
    Celebi Kobak A; Karasu Z; Kilic M; Ozacar T; Tekin F; Gunsar F; Ersoz G; Yuzer Y; Tokat Y
    Transplant Proc; 2007 Jun; 39(5):1488-90. PubMed ID: 17580169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
    Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
    Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Udayakumar VP; Surendran S; Padma UD
    Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.